BIOMAT Database Logo BIOMAT Database Logo

Inhibition of natural anti-inflammatory mechanism by beta 2-agonists. 1991

M Johnson, and R A Coleman, and S Sanjar, and C J Vardey, and C J Whelan, and M M Jenkins

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008407 Mast Cells Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR. Basophils, Tissue,Basophil, Tissue,Cell, Mast,Cells, Mast,Mast Cell,Tissue Basophil,Tissue Basophils
D011943 Receptors, Adrenergic, beta One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS. Adrenergic beta-Receptor,Adrenergic beta-Receptors,Receptors, beta-Adrenergic,beta Adrenergic Receptor,beta-Adrenergic Receptor,beta-Adrenergic Receptors,Receptor, Adrenergic, beta,Adrenergic Receptor, beta,Adrenergic beta Receptor,Adrenergic beta Receptors,Receptor, beta Adrenergic,Receptor, beta-Adrenergic,Receptors, beta Adrenergic,beta Adrenergic Receptors,beta-Receptor, Adrenergic,beta-Receptors, Adrenergic
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000318 Adrenergic beta-Agonists Drugs that selectively bind to and activate beta-adrenergic receptors. Adrenergic beta-Receptor Agonists,beta-Adrenergic Agonists,beta-Adrenergic Receptor Agonists,Adrenergic beta-Agonist,Adrenergic beta-Receptor Agonist,Betamimetics,Receptor Agonists, beta-Adrenergic,Receptors Agonists, Adrenergic beta,beta-Adrenergic Agonist,beta-Adrenergic Receptor Agonist,Adrenergic beta Agonist,Adrenergic beta Agonists,Adrenergic beta Receptor Agonist,Adrenergic beta Receptor Agonists,Agonist, Adrenergic beta-Receptor,Agonist, beta-Adrenergic,Agonist, beta-Adrenergic Receptor,Agonists, Adrenergic beta-Receptor,Agonists, beta-Adrenergic,Agonists, beta-Adrenergic Receptor,Receptor Agonist, beta-Adrenergic,Receptor Agonists, beta Adrenergic,beta Adrenergic Agonist,beta Adrenergic Agonists,beta Adrenergic Receptor Agonist,beta Adrenergic Receptor Agonists,beta-Agonist, Adrenergic,beta-Agonists, Adrenergic,beta-Receptor Agonist, Adrenergic,beta-Receptor Agonists, Adrenergic
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

M Johnson, and R A Coleman, and S Sanjar, and C J Vardey, and C J Whelan, and M M Jenkins
Inhibition of natural anti-inflammatory mechanism by beta 2-agonists.
May 1991, Lancet (London, England),
M Johnson, and R A Coleman, and S Sanjar, and C J Vardey, and C J Whelan, and M M Jenkins
One explanation of the asthma paradox: inhibition of natural anti-inflammatory mechanism by beta 2-agonists.
March 1991, Lancet (London, England),
M Johnson, and R A Coleman, and S Sanjar, and C J Vardey, and C J Whelan, and M M Jenkins
Anti-inflammatory effect of beta 2-agonists: inhibition of TNF-alpha release from human mast cells.
December 1997, The Journal of allergy and clinical immunology,
M Johnson, and R A Coleman, and S Sanjar, and C J Vardey, and C J Whelan, and M M Jenkins
Beta 2-agonists as anti-inflammatory therapies in the lung.
January 1993, Agents and actions. Supplements,
M Johnson, and R A Coleman, and S Sanjar, and C J Vardey, and C J Whelan, and M M Jenkins
Inhibition of phagocyte-endothelium interactions by oxidized fatty acids: a natural anti-inflammatory mechanism?
July 1996, The Journal of laboratory and clinical medicine,
M Johnson, and R A Coleman, and S Sanjar, and C J Vardey, and C J Whelan, and M M Jenkins
Topical anti-inflammatory activity of beta 2-adrenoceptor agonists in the conjunctiva.
January 1985, Journal of ocular pharmacology,
M Johnson, and R A Coleman, and S Sanjar, and C J Vardey, and C J Whelan, and M M Jenkins
Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs.
May 1991, Biochemical pharmacology,
M Johnson, and R A Coleman, and S Sanjar, and C J Vardey, and C J Whelan, and M M Jenkins
Anti-inflammatory effects of long-acting beta-agonists in asthma.
October 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
M Johnson, and R A Coleman, and S Sanjar, and C J Vardey, and C J Whelan, and M M Jenkins
Amorfrutins Are Natural PPARĪ³ Agonists with Potent Anti-inflammatory Properties.
May 2015, Journal of natural products,
M Johnson, and R A Coleman, and S Sanjar, and C J Vardey, and C J Whelan, and M M Jenkins
Histamine release inhibition in anti-inflammatory mechanism.
April 1970, Acta medicinae Okayama,
Copied contents to your clipboard!